Adamas Pharmaceuticals, Inc.: accounts_payable

Value{"amount": 3859000, "concept": "us-gaap:AccountsPayableCurrent", "currency": "USD"}
Period (as of 2015-06-30)
Statuscurrent
EntityAdamas Pharmaceuticals, Inc.
Provenance
Source: SEC EDGAR CompanyFacts (US-PD-17USC105)
Reference: 0001104659-15-058706 · Open the official SEC filing →
Retrieved: 2026-08-19T12:42:17.795211+02:00
Raw response sha256: f7bde1a401b286c74a2fd824ee1df541…
Also addressable by official identifiers: https://factanker.com/fact/sec/cik-0001328143/accounts-payable/2015-06-30 (CIK, metric, reporting date)
Cite as: FACTANKER, https://factanker.com/fact/f0a63ddb-76f9-4f2e-b737-01c3091d3465

History

From the Record
32 US software companies haven’t lost money in a decade. One of them is steadier than all the rest.
Read the findingSearch 53 million companies